Table 1 Baseline characteristics of patients

Age, mean (SD), y

60.5 (6.8)

58.2 (8.7)

59.5 (9.9)

Education, N (%)

 High school or less

40 (71.4%)

40 (71.4%)

17 (60.7%)

 College or more

16 (28.6%)

16 (28.6%)

11 (39.3%)

Employment status, N (%)

 Employed

1 (1.8%)

5 (8.9%)

3 (10.7%)

 Retired

55 (98.2%)

51 (91.1%)

25 (89.4%)

Marital status, N (%)

 Married

48 (85.7%)

53 (94.6%)

21 (75.0%)

 Single/Divorced/Widowed

8 (14.3%)

3 (5.4%)

7 (25.0%)

Body Mass Index, mean (SD), Kg/m²

24.0 (3.3)

22.9 (2.7)

23.4 (3.4)

Months since cancer diagnosis, median (Q₁,Q₃)

28.0 (14.5, 60.0)

28.5 (18.0, 58.3)

40.0 (20.5, 68.5)

Cancer Stage, N (%)

 I

12 (21.4%)

8 (14.3%)

10 (35.71%)

 II

29 (51.8%)

31 (55.4%)

13 (46.4%)

 III

15 (26.8%)

17 (30.4%)

5 (17.9%)

Previous treatments, N (%)

 Surgery

56 (100.0%)

56 (100.0%)

28 (100.0%)

 Chemotherapy

44 (78.6%)

49 (87.5%)

21 (75.0%)

 Radiotherapy

20 (35.7%)

27 (48.2%)

10 (35.7%)

 Hormnal therapy

4 (7.1%)

5 (8.9%)

3 (10.7%)

Present hormonal treatments, N (%)

34 (60.7%)

39 (69.6%)

17 (60.7%)

Number of Comorbidities, N (%)

 0

14 (25.0%)

13 (23.2%)

8 (28.6%)

 1

34 (60.7%)

40 (71.4%)

16 (57.1%)

 2 or more

8 (14.3%)

3 (5.4%)

4 (14.3%)

Baseline Characteristics of Patients, mean (SD) or median (Q₁,Q₃)

 BFI

4.1 (1.6)

3.6 (1.4)

3.9 (1.3)

 PSQI

9.8 (4.6)

9.5 (3.9)

9.0 (3.6)

 FACT-B

103.3 (15.3)

104.1 (14.5)

104.2 (13.0)

 HADS-A

3.5 (0.3, 6.0)

3.0 (1.0, 6.0)

3.5 (1.0, 7.0)

 HADS-D

3.0 (1.0, 5.0)

2.0 (1.0, 5.0)

3.0 (1.0, 8.8)

 PSS-10

11.0 (7.0, 15.0)

11.0 (6.0, 16.8)

12.0 (8.0, 16.8)

 BPI

1.1 (0.0, 2.4)

1.3 (0.4, 3.4)

1.6 (0.2, 2.7)

 AES

16.2 (3.4)

16.2 (3.2)

/